Bill > HJR39

This Joint Resolution directs the Board of Pharmacy to investigate whether kratom, a tropical tree from Southeast Asia whose leaves have psychoactive effects, should be classified as a controlled substance within the Commonwealth. This study is prompted by concerns highlighted in reports from the U.S. Centers for Disease Control and Prevention and a study from Nationwide Children's Hospital, which indicated a significant increase in kratom-related exposures and deaths. The Board of Pharmacy is tasked with determining the number of kratom-related deaths and medical problems in the Commonwealth, the extent of kratom use, any potential health benefits, the costs of classifying it as controlled, and how it should be scheduled if deemed appropriate. All state agencies are required to assist the Board, which must complete its meetings by November 30, 2020, and submit a report of its findings and recommendations to the Governor and the General Assembly by the start of the 2021 Regular Session.